Antidepressants and antianxiety Flashcards
Biologic hypothesis of depression
________
_____________ theory
_______ – _______
Genetics
Monoamine theory
Hormonal – Neuroendocrine
Monoamine theory of depression
Due to a deficit in the monoamine transmitters –___________ and _________ in some regions of the brain
norepinephrine and serotonin
Monoamine theory of depression
Supportive evidence
•The monoamines play a role in _________
•Antidepressants act by facilitating __________
•Drugs that ______________
arousal and mood
noradrenergic and serotonergic transmission
block monoaminergic synthesis and storage
Examples of drugs that block monoaminergic synthesis and storage
???
reserpine, alpha-methyltyrosine, methyldopa
Monoamine hypothesis
Research evidence against monoamine hypothesis
Although levels of norepinephrine and serotonin are increased immediately,
therapeutic effects are seen at _____
Likely a trophic factor
2-3 weeks
Neuroendocrine
Depressed patients have a (low or high?) level of cortisol and does not (rise or fall?) when _______________________ test is carried out
This is thought to occur as a result of a deficiency of _____________ to the __________
High; fall
dexamethasone suppression
noradrenergic and serotonergic input
hypothalamus
Neuroendocrine
Hypothalamus secretes corticotrophin releasing hormone (CRH) which stimulates the pituitary gland to produce ACTH and this further stimulates cortisol
________ level is also increased
_______ hormone is reduced
Prolactin
Growth
Other hypothesis of depression
Low levels of brain derived __________ factors
Increased cortical _______ levels
____________________
neurotrophic
glutamate
Neurodegeneration
What antidepressants are?
Drugs used to treat depression- by ___________
Mainly (inhibitory or excitatory?) to increase monoaminergic transmission
elevate mood
excitatory
Classification of antidepressants
Reversible monoamine oxidase inhibitor (RIMA) –_________,_______
Selective serotonin reuptake inhibitor –_____,_______,_______,_______,________,_______,________
moclobemide, clorgyline
fluoxetine, fluvoxamine, paroxetine, sertraline, citalopram, escitalopram, dapoxetine
Classification of antidepressants
____________(RIMA)
_________ antidepressant
Selective ____________ inhibitor
Serotonin and ———————-
______ antidepressants
Reversible monoamine oxidase inhibitor
Tricyclic antidepressant
Selective serotonin reuptake inhibitor
Serotonin and noradrenaline reuptake inhibitors
Atypical
Atypical antidepressants – ______,_______,_________,______,______,_____________
trazodone, mianserin, mirtazapine, bupropion, atomoxetine, tianepine
Serotonin and noradrenaline reuptake inhibitors – ________,_______
venlafaxine, duloxetine
Monoamine oxidase
MAO – a ___________ enzyme , ________________________ of amines like adrenaline, noradrenaline , dopamine, serotonin
mitochondrial
oxidative deamination
Monoamine oxidase
Two type
MAO –A – Present in _____ nerve endings, _________ and human ______. Preference for _______ and _______
MAO –B –Present in _________ areas in the ________ and ________. Preferentially deaminates _________.
adrenergic; intestinal mucosa; placenta
5-HT and NA.
serotonergic
brain and platelets
phenylethylamine
Monoamine oxidase
___________ is degraded equally by MAO –A and MAO-B
Dopamine
Monoamine oxidase inhibitors
Irreversible – _______ ,———,_______
Reversible
MAO –A __________,__________
MAO –B _____________
phenelzine, tranylcypromine, isocarboxazid
Moclobemide, Clorgyline
Selegiline
Selegiline is not used in depression.
T/F
T
Antidepressant only at high doses
Irreversible monoamine oxidase inhibitors
(Selective or Non-selective?)
No longer in use because of _________ and _____________
Non-selective
drug drug interactions and drug –food interaction (cheese) etc
Irreversible monoamine oxidase inhibitors
Inhibits the enzyme irreversibly – action lasts about ________ until new enzymes are synthesised
3 weeks
Irreversible monoamine oxidase inhibitors
Cheese reaction – reaction with ______, some ___,________,_________ extracts.
Release (small or large?) amount of _____ from adrenergic neurons
Leading to dangerous ______________
cheese
beers, wine and yeast
Large ; noradrenaline
hypertensive crises
Reversible inhibitors of MAO –A
Moclobemide –
•reversible and (selective or non-selective?)
•Duration of action is ______
•Indicated for ____________ depression
•Less adverse reaction – can be displaced by _______ from enzyme binding site
•Adverse effects – nausea , dizziness
•Drug interactions – rare, caution when prescribing with _____________ and _________
selective; 1-2 days
mild to moderate
tyramine
other antidepressants and pethidine
Tricyclic antidepressants
Uptake blocker – inhibit ————- and _________ at the ——— and ——— membranes.
Prolonged accumulation of the monoamines lead to the _______ of the inhibitory presynaptic ______,_______, and _________ auto receptors.
There is also an adaptive change in the postsynaptic receptors leading to _________ noradrenergic and serotonergic transmission.
norepinephrine and serotonin transporter
neuronal and platelet ; desensitization
alpha 2, 5HT1A and 5HT1D
enhanced
Tricyclic antidepressants
Inhibits other receptors
_____ adrenergic,
________ receptors
histaminergic effects H__
5-HT__ and 5-HT___
D___ -
Alpha
Muscarinic
H1
5-HT1 and 5-HT2
D2 -
Pharmacological actions of Tricyclic antidepressants
CNS - Clinical effects seen within _________ of treatment because there is upregulation of the ________ and _______ receptors in the CNS.
Improved ______ pattern.
2 -3 weeks
serotonin and Noradrenaline
sleep
Pharmacokinetics of Tricyclic antidepressants
(Poorly or Well?) but (slowly or rapidly?) absorbed
(Mildly or Highly?) plasma and tissue protein bound
(Small or Large?) vol. of distribution
Metabolism – hepatic microsomal enzyme
Well; slowly
Highly ; Large